Human Recombinant Oncostatin M

Oncostatin M

More Views

From: 202 USD

Options

* Required Fields

Catalog # (Select a product)
Oncostatin M
From: 202 USD

Overview

Oncostatin M (OSM) is a member of interleukin 6 (IL-6) family of cytokines and bears close resemblance to leukemia-inhibitory factor (LIF) and granulocyte colony-stimulating factor (G-CSF) in amino acid sequence and its modulation of differentiation in a variety of cell types (Rose & Bruce). OSM signals through type I receptor (consisting of gp130 and LIF receptor (LIFR)) and type II receptor (consisting of gp130 and OSM receptor (OSMR)), which eventually activate the JAK/STAT pathway (Auguste et al.; Gómez-Lechón). OSM is primarily produced by activated T cells and monocytes, and also by activated macrophages, neutrophils, mast cells, and dendritic cells. OSM is also produced within the bone microenvironment by cells of both hematopoietic and mesenchymal origin including osteocytes and osteoblasts. OSM is involved in differentiation, cell proliferation, hematopoiesis, and inflammation, and also has been shown to have implications in liver development, bone formation and resorption (Sims & Quinn; Tanaka & Miyajima).
Alternative Names:
OSM
Cell Type:
Airway Cells; B Cells; Hematopoietic Stem and Progenitor Cells; Intestinal Cells; Lymphocytes; Neurons; T Cells
Species:
Human
Area of Interest:
Epithelial Cell Biology; Immunology; Neuroscience; Stem Cell Biology
Molecular Weight:
25.9 kDa
Purity:
≥ 95 %

Scientific Resources

Product Documentation

Document Type
Product Name
Catalog #
Lot #
Language

Educational Materials

(2)

Data and Publications

Data

(A) The biological activity of Human Recombinant Oncostatin M was tested by its ability to promote the proliferation of TF-1 cells. Cell proliferation was measured using a fluorometric assay method. The EC50 is defined as the effective concentration of the growth factor at which cell proliferation is at 50% of maximum. The EC50 in the example above is less than 10 ng/mL. (B) 2 μg of Human Recombinant Oncostatin M was resolved with SDS-PAGE under reducing (+) and non-reducing (-) conditions and visualized by Coomassie Blue staining. Human Recombinant Oncostatin M has a predicted molecular mass of 25.9 kDa.

PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED. FOR ADDITIONAL INFORMATION ON QUALITY AT STEMCELL, REFER TO WWW.STEMCELL.COM/COMPLIANCE.